Accurate Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Accurate Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-277	Closed	-$207K	–	600
2026 Q1	$207K	Buy	+277	New	+$212K	0.03%	514
2024 Q4	–	Sell	-229	Closed	-$233K	–	398
2024 Q3	$233K	Sell	229 -6	-3%	-$6.68K	0.05%	335
2024 Q2	$254K	Buy	235 +10	+4%	+$9.69K	0.06%	264
2024 Q1	$202K	Sell	225 -34	-13%	-$32.3K	0.06%	279
2023 Q4	$237K	Sell	259 -15	-5%	-$12.4K	0.07%	241
2023 Q3	$229K	Buy	+274	New	+$215K	0.07%	232
2023 Q2	–	Sell	-279	Closed	-$230K	–	286
2023 Q1	$230K	Buy	279 +23	+9%	+$17.3K	0.08%	224
2022 Q4	$179K	Sell	256 -185	-42%	-$137K	0.07%	222
2022 Q3	$325K	Buy	+441	New	+$278K	0.14%	128

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Accurate Wealth Management's REGN Position: Q2 2026 in Review

Accurate Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 277 shares — an estimated $207K sold.

Accurate Wealth Management first reported a position in REGN in Q3 2022 and held it in 9 quarters. The position peaked at $325K in Q3 2022. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Accurate Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Accurate Wealth Management sold 277 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $207K.
Accurate Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2022 and held it in 9 quarters.
Accurate Wealth Management's Regeneron Pharmaceuticals position peaked at $325K in Q3 2022.
1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.